Antisense Therapeutics Limited (ATHJF) has a market capitalization of $19.64M and trades at $0.01. The 52-week range is 0.01-0.075.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -0.9, Earnings Per Share (EPS) of $-0.01, annual revenue of $2.97M.
The stock has a beta of 0.87, operates in the Healthcare sector.
